SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-013371
Filing Date
2020-01-24
Accepted
2020-01-23 21:44:06
Documents
7
Period of Report
2020-01-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d868443d8k.htm 8-K 29676
2 EX-1.1 d868443dex11.htm EX-1.1 287616
3 EX-4.1 d868443dex41.htm EX-4.1 53241
4 EX-99.1 d868443dex991.htm EX-99.1 12611
5 EX-99.2 d868443dex992.htm EX-99.2 12811
6 GRAPHIC g868443g0123140429360.jpg GRAPHIC 2810
7 GRAPHIC g868443g0123140909045.jpg GRAPHIC 2810
  Complete submission text file 0001193125-20-013371.txt   405253
Mailing Address 540-1385 WEST 8TH AVENUE Vancouver A1 V6H 3V9
Business Address 540-1385 WEST 8TH AVENUE Vancouver A1 V6H 3V9 (604) 678-1388
Zymeworks Inc. (Filer) CIK: 0001403752 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38068 | Film No.: 20543553
SIC: 2834 Pharmaceutical Preparations